Status:
COMPLETED
Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia
Lead Sponsor:
Aga Khan University
Conditions:
Hypercholesterolemia
Hypertension
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
PHASE2
Brief Summary
This is a pilot study. The aim of the investigators' study is to evaluate the effectiveness of nigella sativa seed in the treatment of dyslipidemia. Dyslipidemia is a common risk factor for cardiova...
Detailed Description
* Pakistan is a developing country with limited resources and a high prevalence of dyslipidemia. * Nigella sativa is a small plant originating in the Middle East and is found abundantly, growing wild ...
Eligibility Criteria
Inclusion
- Adult (18 years or older) men and women
- Serum cholesterol \> 180 mgs/dl
- Provide Informed Consent
Exclusion
- Diabetes mellitus
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00327054
Start Date
February 1 2006
End Date
March 1 2007
Last Update
July 1 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aga Khan University
Karachi, Sindh, Pakistan, 74800